Related Experiment Videos
Potential indications for the selective serotonin reuptake inhibitors
1Feighner Research Institute, San Diego, California.
International Clinical Psychopharmacology
|June 1, 1992
Summary
Selective serotonin reuptake inhibitors (SSRIs) show proven effectiveness for major depression and promising results for numerous other conditions. Their broad applications may necessitate rethinking diagnostic categories and antidepressant mechanisms.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Selective serotonin reuptuptake inhibitors (SSRIs) are a class of antidepressants.
- SSRIs include fluoxetine, fluvoxamine, citalopram, paroxetine, and sertraline.
Purpose of the Study:
- To review the efficacy of SSRIs across various psychiatric and non-psychiatric conditions.
- To explore the potential of SSRIs beyond major depression.
Main Methods:
- Literature review of studies on SSRI efficacy.
- Analysis of preliminary data for emerging indications.
Main Results:
- SSRIs are well-established for major depression.
- Preliminary evidence suggests SSRI effectiveness for obsessive-compulsive disorder, panic disorder, eating disorders, substance use disorders, chronic pain, dementia, and personality disorders.
- SSRIs show promise in treating atypical depression and premenstrual tension.
Conclusions:
- The diverse clinical applications of SSRIs challenge traditional diagnostic frameworks.
- Current data suggests a need to re-evaluate how antidepressants function and are categorized.